Holen Sie sich die Stockscreener-App
3.09
1.59%
-0.05
Vorhandelsmarkt:
3.07
-0.02
-0.65%
Schlusskurs vom Vortag:
$3.14
Offen:
$3.13
24-Stunden-Volumen:
824.01K
Relative Volume:
0.35
Marktkapitalisierung:
$235.45M
Einnahmen:
$151.64M
Nettoeinkommen (Verlust:
$-37.23M
KGV:
-5.6552
EPS:
-0.5464
Netto-Cashflow:
$-13.58M
1W Leistung:
+1.98%
1M Leistung:
+52.97%
6M Leistung:
+139.53%
1J Leistung:
-7.21%
1-Tages-Spanne:
$3.04
$3.17
1-Wochen-Bereich:
$2.95
$3.40
52-Wochen-Spanne:
$0.80
$3.71
Neuronetics Inc Stock (STIM) Company Profile
Firmenname
Neuronetics Inc
Sektor
Branche
Telefon
877-600-7555
Adresse
3222 PHOENIXVILLE PIKE, MALVERN, PA
Compare STIM vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
STIM
Neuronetics Inc
|
3.09 | 239.26M | 151.64M | -37.23M | -13.58M | -0.5464 |
ABT
Abbott Laboratories
|
114.14 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
327.70 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
92.30 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
49.37 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.83 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Neuronetics Inc Stock (STIM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-13 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-10-13 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-10-13 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-01-22 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2020-02-06 | Eingeleitet | BTIG Research | Buy |
| 2018-07-24 | Eingeleitet | Canaccord Genuity | Buy |
Alle ansehen
Neuronetics Inc Aktie (STIM) Neueste Nachrichten
Neuronetics (NASDAQ: STIM) ex-officer lines up $464K stock sale - Stock Titan
Neuronetics Expands CFO Nir Naor’s Financial Leadership Role - The Globe and Mail
Neuronetics (NASDAQ: STIM) holder plans $388K sale with part for taxes - Stock Titan
Neuronetics (STIM) Q2 2026 Earnings Call Transcript - AOL.com
Neuronetics (STIM) Edges Lower by 0.91% as Shares Navigate Key Support at $3.11Volume Weighted Price - Vinanet
Neuronetics (STIM) Slips to $3.25 as Shares Hover Near Key SupportPairs Trade - Vinanet
Neuronetics (NASDAQ:STIM) Major Shareholder Buys $44,240.00 in Stock - MarketBeat
Neuronetics director Jorey Chernett buys $44,240 in company stock - Investing.com
Neuronetics 10% owner Jorey Chernett acquires 14,000 common shares worth $44,240 - Bitget
Neuronetics (STIM) 10% holder buys stock, exits call options - Stock Titan
Neuronetics names Nir Naor principal financial and accounting officer - Bitget
symbol__ Stock Quote Price and Forecast - CNN
Neuronetics Stock Price Forecast. Should You Buy STIM? - StockInvest.us
Point72 discloses 5% Neuronetics (STIM) stake in new SEC ownership filing - Stock Titan
US$6.00That's What Analysts Think Neuronetics, Inc. (NASDAQ:STIM) Is Worth After These Results - simplywall.st
Neuronetics Q2 2026 Results: Hybrid NeuroStar Model and Greenbrook Growth Signal Strategic PivotEarnings Preview - Vinanet
Neuronetics, Inc. (STIM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Neuronetics earnings beat by $0.07, revenue topped estimates - Investing.com Nigeria
Neuronetics (STIM) Stock Repriced After Margin Gains And EBITDA Breakeven - Sahm
Neuronetics, Inc. (STIM) stock price, news, quote and history - Yahoo Finance Australia
Neuronetics, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Neuronetics Inc (STIM) (Q2 2026) Earnings Call Highlights: Reven - GuruFocus
Neuronetics Inc (STIM) (Q2 2026) Earnings Call Highlights: Revenue Growth and Margin Expansion ... - Yahoo Finance
Neuronetics (STIM) grows sales as going concern risk emerges under debt covenants - Stock Titan
STIM Maintained by BTIG -- Price Target Raised to $6.00 - GuruFocus
Neuronetics stock price target raised to $6 by BTIG on profitability - Investing.com Nigeria
Earnings call transcript: Neuronetics tops Q2 2026 forecasts as stock jumps 23% - Investing.com Canada
BTIG Research Forecasts Strong Price Appreciation for Neuronetics (NASDAQ:STIM) Stock - MarketBeat
Neuronetics Q2 2026 slides: mental health platform beats on margins By Investing.com - Investing.com Canada
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Neuronetics Q2 Earnings Call Highlights - MarketBeat
Neuronetics Narrows Q2 Loss as Greenbrook Growth Drives 9% Revenue Increase - Yahoo Finance
Why is Neuronetics stock surging today? By Investing.com - Investing.com Nigeria
Neuronetics (NASDAQ:STIM) Announces Earnings Results - MarketBeat
Why is Neuronetics stock surging today? - Investing.com
Neuronetics Q2 2026 slides: mental health platform beats on margins - Investing.com
Neuronetics publishes investor presentation on NeuroStar TMS, Greenbrook clinic network strategy - Bitget
Neuronetics Inc reports results for the quarter ended June 30Earnings Summary - tradingview.com
Neuronetics STIM Draws Buy Rating As Vertical Psychiatry Platform Scales Up - StocksToTrade
Form 8K Neuronetics Inc For: 11 August By Investing.com - Investing.com South Africa
Is Neuronetics Inc (STIM) Positioned for Growth After Q2 Earnings Miss? GF Score: 60/100 - GuruFocus
Neuronetics stock soars 15% on second quarter earnings beat By Investing.com - Investing.com South Africa
Neuronetics (STIM) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
STIM Looks 11.3% Overvalued on GF Value™ - GuruFocus
Neuronetics, Inc. Narrows Earnings Guidance for the Full Year 2026 - marketscreener.com
Neuronetics stock soars 15% on second quarter earnings beat - Investing.com
NEURONETICS ($STIM) Releases Q2 2026 Earnings - Quiver Quantitative
Neuronetics Q2 revenue beats estimates on Greenbrook clinic strength - TradingView
Neuronetics Reports Second Quarter 2026 Results, Highlights Revenue Growth and Improved Adjusted EBITDA - Quiver Quantitative
Neuronetics Reports Second Quarter 2026 Financial and Operating Results - The Manila Times
Neuronetics: Q2 Earnings Snapshot - 10TV
Finanzdaten der Neuronetics Inc-Aktie (STIM)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.76%
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):